Tyrosine kinase inhibitors and survival in advanced or metastatic gastric cancer: a systematic review and meta-analysis.

Front Oncol · 2026 · PMC13053319 · PMID 41952692

Europe PMC DOI

hedged sentence

0.1200

closest p · 2.4× alpha

0.1200

boldest claim

The sentences

did not reach statistical significanceP = 0.12not close (p > 0.1)

DCR was markedly improved (RR 3.98, 95% CI 2.08-7.58, P < 0.0001; moderate certainty), whereas ORR did not reach statistical significance (RR 2.03, 95% CI 0.83-5.01, P = 0.12; low certainty).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.